Loading…
Exicure, Inc. is projected to rise to $1.78 by 2027, a +1% move from its current price of $1.75. XCUR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.64 | $1.75 | $1.86 | +0.01% |
| Jul 14 | $1.60 | $1.75 | $1.91 | +0.02% |
| Jul 15 | $1.57 | $1.75 | $1.95 | +0.03% |
| Jul 16 | $1.55 | $1.75 | $1.98 | +0.04% |
| Jul 17 | $1.52 | $1.75 | $2.01 | +0.05% |
| Jul 18 | $1.50 | $1.75 | $2.04 | +0.06% |
| Jul 19 | $1.48 | $1.75 | $2.07 | +0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.48 | $1.75 | $2.07 | +0.07% |
| Week 2 | $1.39 | $1.75 | $2.21 | +0.15% |
| Week 3 | $1.32 | $1.75 | $2.33 | +0.22% |
| Week 4 | $1.26 | $1.76 | $2.44 | +0.30% |
| Week 5 | $1.21 | $1.76 | $2.54 | +0.37% |
| Week 6 | $1.17 | $1.76 | $2.63 | +0.45% |
| Week 7 | $1.14 | $1.76 | $2.72 | +0.52% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Exicure, Inc. is a Healthcare company with limited current operations. It has historically focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas.
Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. This context places the business in the West Coast biotech milieu, even as its operational scale remains modest.
The description below uses only the supplied facts to outline the asset and its outlook without extrapolation beyond the stated information.
Exicure, Inc. (XCUR) operates in the Healthcare sector and currently trades at $1.75 with a market cap of $11.15M, ranking 5109 by market capitalization.
The stock’s price and volatility are reflected in the 100% annualized volatility figure provided, underscoring a highly reactive price profile in this small-cap space.
Forecasts show a mixed price path with limited upside in the near term and more meaningful upside in the long run. The 2031–2033 period and the 2040–2050 horizon carry the most notable upside, with the 2050 avg price at $6.16 and a max of $14.16, implying substantial potential from current levels. The year-by-year structure includes a neutral stance in 2026 at an average of $1.75 and later a bullish shift in the early 2030s, culminating in a 2050 average of $6.16 and a max of $14.16.
A major floor 64.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.9% away) — a key level to hold.
The nearest ceiling, 90.3% above — a clean break opens room to run.
A major ceiling 171.4% above — clearing it would confirm fresh momentum.
Key XCUR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of XCUR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.85 | Sell | $1.85 | Sell |
| MA 10 | $1.98 | Sell | $1.99 | Sell |
| MA 20 | $2.28 | Sell | $2.23 | Sell |
| MA 50 | $2.76 | Sell | $2.72 | Sell |
| MA 100 | $3.37 | Sell | $3.31 | Sell |
| MA 200 | $4.13 | Sell | $4.23 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.92 | Neutral |
| Stoch RSI (14) | 25.24 | Neutral |
| CCI (20) | -106.15 | Sell |
| Williams %R (14) | -95.19 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -35.90 | Sell |
| Bollinger %B (20,2) | 0.15 | Neutral |
| Stochastic %K (14) | 4.81 | Buy |
| TRIX (15) | -1.37 | Sell |
| Awesome (5,34) | -0.70 | Sell |
| Ultimate (7,14,28) | 32.69 | Neutral |
| Momentum (10) | -0.77 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 1.74 | Buy |
| ADX (14) | 27.52 | Sell |
| ATR (14) | 0.14 | Info |
30-day technical snapshot: sentiment is Bearish, with RSI14 at 30. The stock trades below its SMA50 of $2.76 and far below the SMA200 of $4.13, suggesting near-term weakness.
Support is listed at $1.70 and resistance at $3.33, framing a relatively tight risk boundary given current levels. The 30-day range spans from $1.16 to $2.64, providing context for recent price action.
These numbers indicate a near-term downside bias within a broader, uncertain price trajectory.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.70 | $1.75 | $2.50 | 0% | Neutral | |
| $1.29 | $1.78 | $2.65 | +1% | Neutral | |
| $1.05 | $1.54 | $2.45 | -12% | Neutral | |
| $0.874 | $1.35 | $2.25 | -23% | Bearish | |
| $1.09 | $1.76 | $3.05 | 0% | Neutral | |
| $1.26 | $2.12 | $3.82 | +21% | Bullish | |
| $1.23 | $2.17 | $4.02 | +24% | Bullish | |
| $1.29 | $2.37 | $4.51 | +35% | Bullish | |
| $1.04 | $1.99 | $3.89 | +14% | Neutral | |
| $0.9516 | $1.89 | $3.77 | +8% | Neutral | |
| $1.08 | $2.39 | $5.25 | +37% | Bullish | |
| $2.77 | $6.16 | $14.16 | +252% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.70 | $1.75 | $2.04 | +0.00% |
| August 2026 | $1.36 | $1.65 | $2.08 | -5.55% |
| September 2026 | $1.44 | $1.77 | $2.28 | +6.91% |
| October 2026 | $1.43 | $1.78 | $2.33 | +0.75% |
| November 2026 | $1.39 | $1.75 | $2.33 | -1.74% |
| December 2026 | $1.46 | $1.86 | $2.50 | +6.14% |
Click any year to see its month-by-month XCUR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect XCUR to range from $1.70 to $2.50 through 2026. The $1.75 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The XCUR price prediction for 2027 points to an average of $1.78 (low $1.29, high $2.65) — a potential gain of +1% on today's $1.75. Price action looks broadly range-bound.
In 2028, XCUR is projected to trade between $1.05 and $2.45, averaging $1.54 — a potential decline of -12% from today's $1.75. That is -13% versus the projected 2027 average. A consolidation phase looks the most probable path here.
Exicure, Inc.'s 2029 outlook centres on $1.35, within a $0.874 to $2.25 range. That is -13% versus the projected 2028 average. That marks a -23% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2030, XCUR could reach as high as $3.05, with a base case around $1.76 and support toward $1.09 — roughly 0% from $1.75. A consolidation phase looks the most probable path here.
Expect XCUR to range from $1.26 to $3.82 through 2031. The $2.12 average target implies a +21% move from current prices. That is up +21% on the projected 2030 average. Momentum favours further upside here.
The XCUR price prediction for 2032 points to an average of $2.17 (low $1.23, high $4.02) — a potential gain of +24% on today's $1.75. Buyers look set to stay in control over this stretch.
In 2033, XCUR is projected to trade between $1.29 and $4.51, averaging $2.37 — a potential gain of +35% from today's $1.75. That is up +9% on the projected 2032 average. Momentum favours further upside here.
Exicure, Inc.'s 2034 outlook centres on $1.99, within a $1.04 to $3.89 range. That is -16% versus the projected 2033 average. That marks a +14% change versus current levels. A consolidation phase looks the most probable path here.
By 2035, XCUR could reach as high as $3.77, with a base case around $1.89 and support toward $0.9516 — roughly +8% from $1.75. Price action looks broadly range-bound.
Expect XCUR to range from $1.08 to $5.25 through 2040. The $2.39 average target implies a +37% move from current prices. That is up +27% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The XCUR price prediction for 2050 points to an average of $6.16 (low $2.77, high $14.16) — a potential gain of +252% on today's $1.75. Momentum favours further upside here.
Investing $1,000 in XCUR today (≈ 571.428571 XCUR) could be worth
$3,517.67
+$2,517.67 (+252%) by 2050 · US Dollar
Based on the average projected XCUR price of $6.16 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in XCURwould be worth at today's price.
$1,000 invested in XCUR on Jul 10, 2025 (≈ 137.362633 XCUR) would be worth
$240.38
-$759.62 (-76.0%) today · 0.24× · US Dollar
Based on a XCUR entry price of $7.28 vs. today's $1.75.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.91 | $916.23 | -8.4% |
| 1 month ago | $2.76 | $634.06 | -36.6% |
| 3 months ago | $3.78 | $463.33 | -53.7% |
| 6 months ago | $5.84 | $299.66 | -70.0% |
| 1 year ago | $7.28 | $240.38 | -76.0% |
| All time (5.0y) ago | $220.5 | $7.94 | -99.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our XCUR forecast.
Our base-case forecast reaches $3.50 around 2050.
Implied market cap at $3.50: $22.31M
The multi-year forecast shows a challenging early period followed by a gradual recovery and meaningful upside. In 2026 the min is $1.70, avg $1.75, max $2.50 with ROI 0 and a Neutral sentiment, followed by 2027 with min $1.29, avg $1.78, max $2.65 and ROI 1.5 (Neutral).
Through 2028 the average price falls to $1.54 with a -11.9 ROI, and 2029 shows further weakness at average $1.35 and -22.9 ROI (Bearish).
From 2030 onward the path turns more constructive: 2030 avg $1.76 with ROI 0.5; 2031 avg $2.12 (ROI 21.4); 2032 avg $2.17 (ROI 24); 2033 avg $2.37 (ROI 35.4). The forecast remains bullish into 2040, where the average is $2.39 with ROI 36.7, and culminates in 2050 with an average of $6.16 and a max of $14.16, ROI 251.8 (Bullish).
Overall, the longer-horizon view suggests substantial upside potential, punctuated by near-term volatility and periods of neutral or bearish signals. These figures are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $1.76; min $1.09; max $3.05; ROI 0.5%; sentiment Neutral.
Forecasts show mixed outcomes: Neutral in 2026 and 2027, Bearish in 2029, then Bullish from 2031 onward with higher upside in 2032–2033 and again in 2040 and 2050. ROI ranges from -22.9% (2029) to 251.8% (2050). These are estimates, not guarantees.
By 2040 the max is $5.25 and by 2050 the max is $14.16, so reaching $5 is possible according to the forecast, with much higher upside later in the horizon.
Bearish sentiment with RSI14 at 30. The 30-day range is $1.16–$2.64, current price is $1.75, with support at $1.70 and resistance at $3.33.
Current price is $1.75 and market cap is $11.15M.
Exicure, Inc. Community Discussion
0Share your Exicure, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.